Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium flag Belgium · Delayed Price · Currency is EUR
4.800
-0.130 (-2.64%)
Apr 10, 2026, 5:28 PM CET

Hyloris Pharmaceuticals Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.33-6.34-15.38-11.91-11.58
Depreciation & Amortization
0.920.450.380.150.11
Other Amortization
-0.19-0.120.08-
Loss (Gain) From Sale of Assets
---0.02-
Asset Writedown & Restructuring Costs
--0.09-0.02
Loss (Gain) From Sale of Investments
-0.970.97---
Loss (Gain) on Equity Investments
0.070.080.150.130.19
Stock-Based Compensation
0.67-0.580.540.560.58
Other Operating Activities
-0.65-0.34-0.7-0.060.2
Change in Accounts Receivable
-0.29-1.880.03-0.92-2.07
Change in Inventory
-0.05----
Change in Accounts Payable
-0.420.141.05-0.47-
Change in Other Net Operating Assets
0.070.41.16-0.591.29
Operating Cash Flow
-6.99-6.9-12.81-13.02-11.25
Capital Expenditures
-0-0.03-0.3-0.1-0.11
Sale (Purchase) of Intangibles
-0.63-0.27-0.45-0.64-0.74
Investment in Securities
-1.9-10-10.5-2.23
Other Investing Activities
0.40.560.640.52-0
Investing Cash Flow
-2.130.269.89-11.37-3.08
Long-Term Debt Issued
-0.140.05--
Total Debt Issued
-0.140.05--
Long-Term Debt Repaid
-0.34-0.31-0.17-7.46-0.06
Net Debt Issued (Repaid)
-0.34-0.17-0.12-7.46-0.06
Issuance of Common Stock
---17.17-
Other Financing Activities
-0.09--0.01-1.88-
Financing Cash Flow
-0.43-0.17-0.137.84-0.06
Foreign Exchange Rate Adjustments
-0.27----
Miscellaneous Cash Flow Adjustments
0--0--
Net Cash Flow
-9.82-6.81-3.05-16.56-14.39
Free Cash Flow
-7-6.93-13.11-13.12-11.36
Free Cash Flow Margin
-79.23%-71.03%-348.66%-549.69%-366.83%
Free Cash Flow Per Share
-0.25-0.25-0.47-0.48-0.44
Cash Interest Paid
0.09-0.011.88-
Cash Income Tax Paid
---0.35-
Levered Free Cash Flow
-6.53-5.1-7.53-10.4-3.54
Unlevered Free Cash Flow
-6.06-5.05-7.5-10.27-3.2
Change in Working Capital
-0.69-1.342.23-1.98-0.78
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.